Johnson & Johnson to acquire $2 billion drug developer “Ambrx Biopharma” to treat Turbo Cancers with same tech as Pfizer’s $43 billion Seagen acquisition. Both set their sights on 2025 Cancer TSUNAMI

[Nat Quinn]

https://makismd.substack.com/p/johnson-and-johnson-to-acquire-2

[Author]

Posts